BSE filing, BSE: 544106. Summary written from the filing by ALFA Finder's alert engine.
Mayank Cattle Food Ltd: key numbers
- Share price
- ₹151.65
- Market cap
- ₹163.8 Cr
- Revenue (annual)
- ₹403.2 Cr
- Net profit (annual)
- ₹6.02 Cr
- P/E (TTM)
- 27.2×Sector 28.6×
- Promoter holding
- 65.00%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mayank Cattle Food Ltd
All →Mayank Cattle Food Capacity Expansion: ₹25 Cr Investment
Board approved entry into retail segment with Rs.25 Crore investment for ~500 outlets. Company will launch various products in this new channel.
- Value
- ₹25.00 Cr
- retail outlets
- 500 outlets
Mayank Cattle Food Board Meeting Date
Mayank Cattle Food Ltd scheduled its board for November 4, 2026, to consider retail market entry and product launches. No decisions or monetary values are yet confirmed.
Mayank Cattle Food Results Update
Mayank Cattle Food announced H1 FY27 results showing PAT of Rs.5.55 Cr, up 119.73% YoY. Revenue rose 12.56% to Rs.208.67 Cr on improved demand and efficiency.
Mayank Cattle Food H1 FY27 Results: Net Profit ₹5.5 Cr, Up 120.0% YoY
Mayank Cattle Food Ltd reported revenue from operations of ₹208.7 Cr (+12.6% YoY) and net profit of ₹5.5 Cr (+120.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.5 Cr · +120.0% YoY
Mayank Cattle Food Board Meeting Date
Mayank Cattle Food Ltd will hold a board meeting on October 27, 2026, to consider and approve its unaudited financial results for the half-year period.
Mayank Cattle Food Other Announcement
Mayank Cattle Food Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, pursuant to Regulation 31(1)(b) of the SEBI LODR Regulations.
Other capital structure change announcements
All →Jyothy Labs Capital Structure Change
Jyothy Labs' board approved a Rs 147 Crore share buyback via tender offer at Rs 215 per share. The record date is November 11, 2026.
- Value
- ₹147.0 Cr
Evonile Pharma Capital Structure Change
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as record date for a partly paid rights issue of 1,02,87,832 shares at Rs.860 each. Issue size is Rs.8,847.54 Million, with issue opening November 19, 2026.
- Value
- ₹884.8 Cr
- Execution
- Issue opening 19 Nov 2026 to closing 3 Dec 2026; listing on or about 9 Dec 2026
Share India Securities Capital Structure Change
Share India Securities allotted 44,02,000 equity shares under its Silverleaf Capital amalgamation scheme. It also granted 3,80,500 employee stock options under ESOS-II.
Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr